Evaluation of the effect of clinical pharmacists' intervention on deep vein thrombosis prevention in patients undergoing major orthopedic surgery
WANG Yan-li
DING Liang
JIAO Ping
FU Ruo-peng
ZHU Man
Abstract:Objective: Clinical pharmacist evaluate effect of prevention of deep vein thrombosis in patients undergoing major orthopedic surgery before and after pharmaceutical intervention. Methods:A total of 147 cases undergoing major orthopedic surgery from June 2015 to May 2017 in a grade hospital were collected, among which 72 cases from June 2016 to May 2017 were enrolled in intervention group and 75 cases from June 2015 to May 2016 were enrolled in control group. Basic information of patients, incidence of deep vein thrombosis, risk evaluation, basic protective measure and awareness rate of drug prophylaxis were retrospectively and statistically analyzed by SPSS 18.0 software. Results:There was no significant difference in the basic data between the two groups (P > 0.05). In intervention group, the incidence of deep venous thrombosis was significantly lower than that in control group (P < 0.05). Compared with control group, the risk assessment rate of deep venous thrombosis and the utilization rate of basic prophylaxis in intervention group were increased by 87% and 13% respectively. There was a significant difference (P < 0.05) between the two groups in awareness rate of drug prophylaxis (except the selection of preventive drugs). Conclusion:Clinical pharmacists intervened the prevention of deep vein thrombosis in patients undergoing major orthopedic surgery. Meanwhile, the incidence of deep vein thrombosis reduced significantly after intervention.
Keywords:Clinical pharmacistOrthopedic surgeryPreventionDeep vein thrombosisEvaluation
Publication Date:2018-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:4( 307-310 )
